Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian P Sinha

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Plos Medicine|February 2, 2011
Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studiesIan P Sinha, Rosalind L Smyth, Paula R Williamson
The Cochrane Database of Systematic Reviews|March 3, 2023
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha A Aslam, Ian P Sinha, Kevin W Southern
Pediatric Pulmonology|February 18, 2026
Installing Air Purifiers in the Homes of Children With Severe Asthma: Outcomes and Family Perspectives From a Feasibility StudyKarl A Holden, Daniel B Hawcutt, Ian P Sinha
Plos One|July 18, 2009
Outcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focussed on short term disease activityIan P Sinha, Paula R Williamson, Rosalind L Smyth
Paediatric Respiratory Reviews|March 25, 2025
Socioeconomic determinants of outcomes in childhood asthmaKarl A Holden, Daniel B Hawcutt, Ian P Sinha
The Cochrane Database of Systematic Reviews|December 17, 2020
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Kevin W Southern, Jared Murphy, Ian P Sinha, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 18, 2020
Commercial valved spacers versus home-made spacers for delivering bronchodilator therapy in pediatric acute asthma: a cost-effectiveness analysisCarlos E Rodríguez-Martínez, Monica P Sossa-Briceño, Ian P Sinha
Pediatric Pulmonology|March 8, 2021
When adherence and inhalation technique matter: Difficult-to-control pediatric asthma in low- to middle-income countriesCarlos E Rodriguez-Martinez, Monica P Sossa-Briceño, Ian P Sinha
Trials|July 4, 2012
Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young peopleIan P Sinha, Ruairi Gallagher, Paula R Williamson, et al.
The Cochrane Database of Systematic Reviews|August 3, 2018
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosisKevin W Southern, Sanjay Patel, Ian P Sinha, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Plos Medicine|February 2, 2011
Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studiesIan P Sinha, Rosalind L Smyth, Paula R Williamson
The Cochrane Database of Systematic Reviews|March 3, 2023
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha A Aslam, Ian P Sinha, Kevin W Southern
Pediatric Pulmonology|February 18, 2026
Installing Air Purifiers in the Homes of Children With Severe Asthma: Outcomes and Family Perspectives From a Feasibility StudyKarl A Holden, Daniel B Hawcutt, Ian P Sinha
Plos One|July 18, 2009
Outcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focussed on short term disease activityIan P Sinha, Paula R Williamson, Rosalind L Smyth
Paediatric Respiratory Reviews|March 25, 2025
Socioeconomic determinants of outcomes in childhood asthmaKarl A Holden, Daniel B Hawcutt, Ian P Sinha
The Cochrane Database of Systematic Reviews|December 17, 2020
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Kevin W Southern, Jared Murphy, Ian P Sinha, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 18, 2020
Commercial valved spacers versus home-made spacers for delivering bronchodilator therapy in pediatric acute asthma: a cost-effectiveness analysisCarlos E Rodríguez-Martínez, Monica P Sossa-Briceño, Ian P Sinha
Pediatric Pulmonology|March 8, 2021
When adherence and inhalation technique matter: Difficult-to-control pediatric asthma in low- to middle-income countriesCarlos E Rodriguez-Martinez, Monica P Sossa-Briceño, Ian P Sinha
Trials|July 4, 2012
Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young peopleIan P Sinha, Ruairi Gallagher, Paula R Williamson, et al.
The Cochrane Database of Systematic Reviews|August 3, 2018
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosisKevin W Southern, Sanjay Patel, Ian P Sinha, et al.
Pageof 6